Bosutinib In Subjects With Renal Impairment

NCT01233882 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Disease, End-Stage
Renal Insufficiency, Chronic
Renal Insufficiency, Acute

Interventions

DRUG: Bosutinib
DRUG: Bosutinib
DRUG: Bosutinib
DRUG: Bosutinib

Sponsor

Pfizer